Date:2/17/2010

channel stakeholders, the flow of drugs and dollars among those entities, and the significance of the retail pharmacy sector.  The course then explains retail pharmacy dynamics and what happens in the pharmacy, from the prescription to the patient receiving their medications, and who influences that process.  The course concludes with opportunities and approaches for representatives to better partner with pharmacies.

For more information on the Employers e-course, please visit

http://www.pharmainstitute.com/training-solutions/managed-markets/employers/index.cfm

For more information on the Retail Pharmacy e-course, please visit

http://www.pharmainstitute.com/training-solutions/managed-markets/retail-pharmacy/index.cfm

For more information on Managed Markets Excellence® Series, please visit

http://www.pharmainstitute.com/training-solutions/managed-markets/index.cfm

About Pharmaceutical Institute

Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotec
'/>"/>

SOURCE Pharmaceutical Institute Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results